Accreditation

Accreditation for this course is pending.

Upon completion of this course, participants will be able to:

Describe how advances in our understanding of pathophysiology and natural progression of type 1 and type 2 diabetes have resulted in a more integrated consideration of comorbidities into the design of glycemic treatments.
Identify strategies to optimize the impact of lifestyle interventions in the treatment of diabetes and related conditions.
Summarize appropriate, evidence-based treatment guidelines from recognized, expert organizations for the treatment of diabetes.
Discuss new and evolving pharmacologic and electronic tools that currently or potentially impact the treatment design, efficacy, and/or safety of glycemic control programs.
Demonstrate skills in advancing therapies for glycemic control aimed at achieving recommended treatment targets.
Identify strategies to care for patients with diabetes-related comorbidities and complications based on updated knowledge of state-of-the-art treatment advances.
Explain strategies to identify and then overcome clinical practice barriers emanating from patients, providers, and practice systems issues.
Communicate with patients, families, and health team members in a responsive manner that supports a team approach to the promotion and maintenance of health and prevention and treatment of disease in individuals with diabetes.